Celcuity · 3 weeks ago
Senior or Principal Scientist, Formulation and Process Development
United States
Full-time
Remote
Senior Level, Lead/Staff
$150K/yr - $175K/yr
7+ years expCelcuity is a clinical-stage biotechnology company focused on developing targeted therapies for cancer patients. They are seeking a Senior or Principal Scientist in Formulation and Process Development to lead projects in drug product development and lifecycle management for their oncology drug candidates.
BiotechnologyHealthcareMedical DeviceHealth CareHealth DiagnosticsTherapeutics
Responsibilities
Lead projects to support development of novel and existing formulations, spanning the product lifecycle including pre-formulation, dosage form selection, formulation development, process development, and manufacturing scale-up
Design, execute, and interpret formulation and process development experiments in an outsourced environment at contract laboratories and CDMOs
Identify and vet new contract organizations to support formulation and process development
Help define & execute the project plans for formulation lifecycle management
Support writing technical sections for intellectual property and regulatory filings
Develop and maintain an in-depth knowledge of formulation development trends, techniques, and technologies
Serve as a subject matter expert for formulation development within the Pharmaceutical Development group and the broader Celcuity team
Summarize, document, and present information to subgroup, group, and cross-functional audiences
Other duties as assigned
Qualification
Required
Ph.D/M.S./B.S. in Pharmaceutical Science, Chemical Engineering, Chemistry, Biochemistry, Biochemical Engineering, or related fields
7+ years of experience in pharmaceutical development (preferred 4+ years industry experience for Ph.D; 5+ years for M.S.; 7+ years for B.S.)
Demonstrated experience with formulation development and drug product development, preferably for small molecule drugs
Deep understanding of formulation techniques & considerations for sterile, parenteral dosage forms
Experience with physicochemical characterization methods for drug substances and drug products
Excellent written and verbal communication skills, with ability to influence and build credibility at all levels
Strong interpersonal skills for interacting with colleagues across various levels and functions
Attention to detail and ability to manage multiple processes and documentation requirements
Strong technical and analytical skills with advanced knowledge in MS Office products
Ability to work in a team or independently as required
Outstanding organizational skills with the ability to prioritize
Demonstrated independent and sound decision-making skills; ability to think critically and make decisions in a fast-paced environment
Flexible and willing to learn; able to adapt to business and site needs in a dynamic environment
Maintain a positive, approachable and professional attitude
Preferred
Experience with drug device combination products for injectable drug products (e.g., prefilled syringes, autoinjectors) is preferred
Technical expertise in formulation strategies and processes specifically tailored to poorly water-soluble APIs is preferred
Subject matter expertise in one or more of these areas is highly desirable: Nano-milling and nanosuspension formulation, Micro/nano-emulsions, Salt formation and salt screening/selection, Complexation and co-solvency using cyclodextrins or co-solvents, Lyophilization
Benefits
Annual performance incentive bonus
New hire equity package
Medical insurance
Dental insurance
Vision insurance
401(k) match
PTO
Paid holidays
Company
Celcuity
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.6BKey Investors
Innovatus Capital Partners,Oxford Finance LLCInnovatus Capital PartnersVenrock Healthcare Capital Partners
2026-06-03Post Ipo Debt· $500M
2025-09-09Post Ipo Debt· $500M
2025-07-30Post Ipo Equity· $85M
Leadership Team
Brian Sullivan
Co-Founder, Chairman, CEO
Lance Laing
Chief Science Officer/Co-founder
Recent News
2026-07-16
Company data provided by crunchbase